NINDS Clinical Trial Networks (Other Transactions)
Funds clinical trial networks for neurological conditions through coordinated authority-based multi-center infrastructure.
About
NINDS Clinical Trial Networks use Other Transaction Authority to fund the institute's major trial networks through Research Opportunity Announcements. The active networks are NeuroNEXT for exploratory clinical trials and biomarker studies, StrokeNet STEP for endovascular therapy, and URGenT for gene-based therapies for ultra-rare neurological diseases.
The funding vehicle is OT2, with a two-stage…
BiotechMedtechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.